<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2019.9853</article-id>
<article-id pub-id-type="publisher-id">mmr-19-03-2211</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sodium azide induces mitochondria-mediated apoptosis in PC12 cells through Pgc-1&#x03B1;-associated signaling pathway</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Zuo</surname><given-names>Yuanyi</given-names></name>
<xref rid="af1-mmr-19-03-2211" ref-type="aff">1</xref>
<xref rid="af2-mmr-19-03-2211" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Jun</given-names></name>
<xref rid="af1-mmr-19-03-2211" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Xu</surname><given-names>Xuehua</given-names></name>
<xref rid="af1-mmr-19-03-2211" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Gao</surname><given-names>Xiangting</given-names></name>
<xref rid="af1-mmr-19-03-2211" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yun</given-names></name>
<xref rid="af1-mmr-19-03-2211" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Shaohua</given-names></name>
<xref rid="af1-mmr-19-03-2211" ref-type="aff">1</xref>
<xref rid="c1-mmr-19-03-2211" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-19-03-2211"><label>1</label>Department of Forensic Medicine, Medical College of Soochow University, Suzhou, Jiangsu 215123, P.R. China</aff>
<aff id="af2-mmr-19-03-2211"><label>2</label>Department of Forensic Identification, Binhai People&#x0027;s Hospital, Yancheng, Jiangsu 224500, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-19-03-2211"><italic>Correspondence to</italic>: Professor Shaohua Zhu, Department of Forensic Medicine, Medical College of Soochow University, 178 East Gan Jiang Road, Suzhou, Jiangsu 215123, P.R. China, E-mail: <email>zhushaohua@suda.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="ppub"><month>03</month><year>2019</year></pub-date>
<pub-date pub-type="epub"><day>14</day><month>01</month><year>2019</year></pub-date>
<volume>19</volume>
<issue>3</issue>
<fpage>2211</fpage>
<lpage>2219</lpage>
<history>
<date date-type="received"><day>21</day><month>03</month><year>2018</year></date>
<date date-type="accepted"><day>27</day><month>11</month><year>2018</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Zuo et al.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Sodium azide (NaN<sub>3</sub>), an inhibitor of cytochrome oxidase, induces the release of excitotoxins via an energy impairment and this, in turn, results in neurodegeneration. The present study aimed to investigate the toxic effects NaN<sub>3</sub> on apoptosis of PC12 cells and its mechanism of action in peroxisome proliferator-activated receptor &#x03B3; co-activator 1-&#x03B1; (Pgc-1&#x03B1;)-associated signaling pathways. To induce apoptosis, PC12 cells were exposed to NaN<sub>3</sub> (0, 5, 10, 20, 40 and 80 mM) for 12, 24, 48 and 72 h. Cell viability was determined by CCK-8 assay. DAPI staining was employed to additionally examine apoptotic cells and their nuclear changes. Production of reactive oxygen species (ROS), mitochondrial membrane potential (&#x0394;&#x03A8;m) and apoptotic rate were also assessed by flow cytometry. Cellular ATP content was estimated by firefly luciferase assay. In addition, the expression levels of B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), phosphorylated (p)-Ca<sup>2&#x002B;</sup>/calmodulin-dependent protein kinase (CaMK), p-p38 mitogen-activated protein kinase (p38 MAPK), Pgc-1&#x03B1;, nuclear respiratory factor (Nrf)-1, mitochondrial transcription factor A (Tfam), p-extracellular signal-regulated kinase (Erk)1/2, Nrf-2 and complex IV (Cox IV) were determined by western blot analysis. The data suggested that NaN<sub>3</sub> may induce PC12 cell injury and dose-dependently decrease the cell viability. The expression levels of pro-apoptotic proteins Bax and cytochrome c were upregulated, while the expression levels of anti-apoptotic proteins procaspase-3 and Bcl-2 were downregulated. In addition, the phosphorylation of MAPK and Ca<sup>2&#x002B;</sup>/calmodulin-dependent protein kinase II (CaMKII) family members including pan-calcineurin A was increased, in particular the ratios of p-p38/p38 and p-CaMKII/CaMKII. However, the expression levels of Pgc-1&#x03B1; and its associated proteins, including Nrf-1/2, Tfam and p-Erk1/2 were decreased. In addition, mitochondria were the target organelles of NaN<sub>3</sub>-induced toxicity in PC12 cells, which moderated the dissipation of &#x0394;&#x03A8;m, preserved the cellular ATP content, promoted the production of ROS and increased the apoptotic rate. These results suggested that NaN<sub>3</sub> induced cell death in PC12 cells via Pgc-1&#x03B1;-associated signaling pathways and provided a theoretical basis for additional investigation of the neurotoxic mechanism of NaN<sub>3</sub>, with applications in neurodegenerative disorders.</p>
</abstract>
<kwd-group>
<kwd>sodium azide</kwd>
<kwd>PC12 cells</kwd>
<kwd>apoptosis</kwd>
<kwd>mitochondria</kwd>
<kwd>nuclear co-activator of peroxisome proliferator-activated receptor &#x03B3;</kwd>
<kwd>toxicology</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>As a white, colorless and crystalline powder, sodium azide (NaN<sub>3</sub>) is classed as a highly toxic substance. Its toxic effects are similar to those of cyanide, and it injures the nervous and cardiovascular systems, eyes and skin. This toxic element becomes active rapidly following ingestion, and its major effects occur several hours following oral intake, depending on the amount ingested (<xref rid="b1-mmr-19-03-2211" ref-type="bibr">1</xref>,<xref rid="b2-mmr-19-03-2211" ref-type="bibr">2</xref>). Exposure to NaN<sub>3</sub> may induce a number of symptoms within minutes, including nausea, vomiting, headache, restlessness, dizziness, weakness, rapid breathing and rapid heartbeat (<xref rid="b3-mmr-19-03-2211" ref-type="bibr">3</xref>). High amounts of this toxic element immediately induce convulsions, loss of consciousness, low heart rate and blood pressure, and respiratory failure, eventually leading to mortality (<xref rid="b3-mmr-19-03-2211" ref-type="bibr">3</xref>). Among the demonstrated action mechanisms of NaN<sub>3</sub>, the most relevant one is cytochrome c oxidase-respiratory chain complex-inhibition (<xref rid="b4-mmr-19-03-2211" ref-type="bibr">4</xref>). Previous studies have revealed that NaN<sub>3</sub>, an inhibitor of complex IV (Cox IV), may induce apoptosis in primary cortical neurons, which is caspase-3 dependent and associated with the release of cytochrome c (<xref rid="b5-mmr-19-03-2211" ref-type="bibr">5</xref>).</p>
<p>In mitochondrial biosynthesis, the promoter of respiratory chain Cox IV may be activated by nuclear respiratory factors (Nrf)-1/2. Concomitantly, Nrf may be adjusted by regulating the activity of genes encoding mitochondrial transcription factor A (Tfam) to indirectly regulate the expression levels of respiratory chain genes. Nrf-1/2, Tfam, peroxisome proliferator-activated receptor &#x03B3; co-activator 1-&#x03B1; (Pgc-1&#x03B1;) and other co-activators constitute the Pgc-1&#x03B1; signal cascade, which serves a central role in a regulatory network governing the transcriptional control of mitochondrial biogenesis and respiratory function. In this signal cascade, Pgc-1&#x03B1; first activates Nrf-1/2 as opposed to directly binding to the mitochondrial DNA, and Nrf-1/2 induces the activation of Tfam in combination with the promoter of Tfam and triggers the transcription and replication of mitochondrial DNA, leading to increased expression levels of mitochondrial proteins (<xref rid="b6-mmr-19-03-2211" ref-type="bibr">6</xref>). Concurrently, Pgc-1&#x03B1; may be activated by CaN-, Ca<sup>2&#x002B;</sup>/calmodulin-dependent protein kinase (CaMK)-, mitogen-activated protein kinase (MAPK)- and cyclin-dependent kinase-mediated signaling pathways (<xref rid="b7-mmr-19-03-2211" ref-type="bibr">7</xref>). In the present study, PC12 cells were used to generate a dopamine neuron model, and the effects and mechanism of NaN<sub>3</sub> on the Pgc-1&#x03B1;-associated pathways in PC12 cells were investigated, to identify whether NaN<sub>3</sub> induced toxicity in cultured PC12 cells and the underlying mechanisms involved in these effects.</p>
<p>Materials and methods</p>
</sec>
<sec sec-type="materials">
<title>Materials</title>
<p>Rat pheochromocytoma PC12 cells were purchased from the Cell Bank of Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). Stock solution of NaN<sub>3</sub> (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) was dissolved in the sterile saline to make a 1 M stock solution, which was subsequently diluted to desired concentrations prior to experimentation. A one-step TUNEL Apoptosis Assay kit (C1090), Annexin V-fluorescein isothiocyanate (FITC) Apoptosis Detection kit (C1063), Enhanced adenosine 5&#x2032;-triphosphate (ATP) Assay kit (S0027), JC-1 Mitochondrial Membrane Potential Assay kit (C2006) and Reactive Oxygen Species Assay kit (S0033) were provided by Beyotime Institute of Biotechnology (Haimen, China).</p>
<sec>
<title/>
<sec>
<title>Cell culture and viability assay</title>
<p>PC12 cells were maintained in Dulbecco&#x0027;s modified Eagle&#x0027;s medium (DMEM; Hyclone; GE Healthcare Life Sciences, Logan, Logan, UT, USA) supplemented with 10&#x0025; fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and 1&#x0025; Antibiotic Antimycotic solution consisting of 10,000 U penicillin and 10,000 U streptomycin. The cells were incubated at 37&#x00B0;C in humidified atmosphere of 5&#x0025; CO<sub>2</sub> and always used at 70&#x2013;80&#x0025; confluence.</p>
<p>The viability of PC12 cells was determined using a Cell Counting Kit (CCK-8; Dojindo Molecular Technologies, Inc., Shanghai, China). Cells were seeded into 96-well plates at a density of 1&#x00D7;10<sup>5</sup>/well. After 24 h culture, cells were treated with NaN<sub>3</sub> (0&#x2013;80 mM) and incubated for 12, 24, 48 and 72 h to establish the cell injury model. Subsequently, 10 &#x00B5;l CCK-8 solution (Dojindo Molecular Technologies, Inc.) was added to each well and incubated for an additional 2 h under the standard conditions (37&#x00B0;C and 5&#x0025; CO<sub>2</sub>). The absorbance at a wavelength of 450 nm was determined by ELx808 Absorbance Microplate Reader (BioTek Instruments, Inc., Winooski, VT, USA). The cell viability was calculated according to the mean optical density of 6 wells. The experiments were conducted in triplicate. The appropriate concentrations of NaN<sub>3</sub> for use in subsequent experiments were determined according the results of the cell viability assays.</p>
</sec>
<sec>
<title>Nuclear morphology of DAPI-stained PC12 cells</title>
<p>PC12 cells were exposed to 0, 10, 20 and 40 mM NaN<sub>3</sub> for 24 h. In order to distinguish programmed cell death from non-apoptotic cell death, nuclei were stained with 10 &#x00B5;g/ml DAPI (C1005; Beyotime Institute of Biotechnology). Briefly, cells were washed twice with PBS and then fixed with 4&#x0025; paraformaldehyde at room temperature for 30 min. Subsequent to three washes, fixed cells were stained with DAPI (1:5,000) for 5 min and then washed with PBS. Fluorescence images were acquired with a Leica DMI fluorescence microscope (magnification, &#x00D7;400).</p>
</sec>
<sec>
<title>Measurement of apoptotic rate</title>
<p>An Annexin V-FITC/PI Apoptosis Detection kit (Beyotime Institute of Biotechnology) was used to determine apoptosis of cells according to the manufacturer&#x0027;s instructions. Experiments were repeated in triplicate and were performed as follows: The apoptotic rates of control PC12 cells (0 mM NaN<sub>3</sub>) and PC12 cells exposed to 10, 20 and 40 mM NaN<sub>3</sub> for 24 h was measured by flow cytometry (FC500; Beckman Coulter, Inc., Brea, CA, USA). Statistical analyses were conducted with SPSS statistical software v.13.0 (SPSS, Inc., Chicago, IL, USA).</p>
</sec>
<sec>
<title>Measurement of mitochondrial membrane potential (&#x0394;&#x03A8;m)</title>
<p>&#x0394;&#x03A8;m is a significant parameter of mitochondrial function. It was assessed using staining with JC-1, a fluorescent probe. Experiments were repeated in triplicate, and were performed as follows: Control PC12 cells were treated with 0 mM NaN<sub>3</sub>; and experimental PC12 cells were exposed to 10, 20 and 40 mM NaN<sub>3</sub> for 24 h. Subsequently, according to the manufacturer&#x0027;s protocol (C2006; Mitochondrial Membrane Potential Assay kit; Beyotime Institute of Biotechnology, Haimen, China), cells were incubated with the medium containing JC-1 (1X) at 37&#x00B0;C for 20 min, the cells were washed three times with wash buffer and collected with fresh medium without serum. Concomitantly, the positive control was treated with carbonyl cyanide 3-chlorophenylhydrazone (CCCP), an inhibitor, (10 &#x00B5;M) at 37&#x00B0;C for 20 min. Then, the red/green fluorescence was determined by FCM (FC500; Beckman Coulter, Inc.). The ratios of red fluorescence intensity over green fluorescence intensity represented the levels of &#x0394;&#x03A8;m.</p>
</sec>
<sec>
<title>Measurement of reactive oxygen species (ROS) production</title>
<p>ROS in PC12 cells was assessed using a Reactive Oxygen Species Assay kit (S0033; Beyotime Institute of Biotechnology, Haimen, China). Intracellular ROS generation was assessed by means of 2&#x2032;,7&#x2032;-dichlorofluorescein diacetate (DCFH-DA), a fluorescent probe. Intracellular ROS oxidizes DCFH-DA, yielding the fluorescent compound 2&#x2032;,7&#x2032;-dichlorofluorescein (DCF), and DCF fluorescence intensity is considered to be parallel to the amount of formed ROS, according to the instructions of the ROS assay kit. Experiments were repeated in triplicate and performed as follows: Positive control were treated with specific concentration of Rosup (50 mg/ml); control PC12 cells were treated with 0 mM NaN<sub>3</sub>; and experimental PC12 cells were exposed to 10, 20 and 40 mM NaN<sub>3</sub> for 24 h. In addition, PC12 cells were treated with DCFH-DA (10 mM) dissolved in serum-free DMEM (1:1,000) for 20 min at 37&#x00B0;C and then washed three times with serum-free DMEM. The positive control was treated with Rosup, to induce ROS production. The ROS production was determined by FCM (FC500; Beckman Coulter, Inc.). The Mean fluorescence intensities (MFI) represented the levels of ROS.</p>
</sec>
<sec>
<title>Measurement of cellular ATP content in PC12 cells</title>
<p>Experiments were repeated in triplicate and performed as follows: Control PC12 cells were treated with 0 mM NaN<sub>3</sub>; and experimental PC12 cells were exposed to NaN<sub>3</sub> at different concentrations (10, 20 and 40 mM) for 24 h. Subsequently, the cellular ATP content was determined using a Firefly Luciferase ATP Assay kit (Beyotime Institute of Biotechnology) according to the protocol of the manufacturer.</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>PC12 cells were exposed to 0, 10, 20 and 40 mM NaN<sub>3</sub> for 24 h, lysed in radioimmunoprecipitation assay lysis buffer (Beyotime Institute of Biotechnology) containing a protease inhibitor and centrifuged at 13,362 &#x00D7; g for 10 min at 4&#x00B0;C in order to collect the supernatants. Subsequently, the protein concentrations were determined using BCA kit (Pierce; Thermo Fisher Scientific, Inc.). Equal amounts of proteins (90 &#x00B5;g) were subjected to 10 and 12&#x0025; SDS-PAGE, and then transferred onto polyvinylidene fluoride membranes (0.45 &#x00B5;m) using a Semidry Electro-transfer Unit (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Following blocking with 5&#x0025; bovine serum albumin in TBS containing 0.1&#x0025; Tween-20 (TBST) for 2 h at room temperature, the membranes were incubated with primary antibodies against Pgc-1&#x03B1; (Abcam, Cambridge, MA, USA; 1:500), Nrf-2 (Abcam; 1:500), Cox IV (Abcam; 1:1,000), Tfam (Abcam; 1:1,000), procaspase-3 (Abcam; 1:500), Nrf-1 (Cell Signaling Technology, Inc., Danvers, MA, USA, 1:500), pan-calcineurin A (CaN; Cell Signaling Technology Inc.; 1:1,000), phosphorylated (p)-CaMKII (Cell Signaling Technology; 1:1,000), p-p38 MAPK (Cell Signaling Technology, Inc.; 1:1,000), p-extracellular signal-regulated kinase (Erk)1/2 (Cell Signaling Technology, Inc.; 1:1,000), B-cell lymphoma-2 (Bcl-2)-associated X protein (Bax; Santa Cruz Biotechnology, Inc., Dallas, TX, USA; 1:200), Bcl-2 (Santa Cruz Biotechnology, Inc.; 1:200) and cytochrome c (Santa Cruz Biotechnology, Inc.; 1:200) at 4&#x00B0;C overnight. The membranes were then washed with TBST and incubated with horse-radish peroxidase (HRP)-conjugated secondary antibodies (rabbit; cat. no. A0208; 1:1,000; or mouse; cat. no. A0216; 1;1,000; both Beyotime Institute of Biotechnology) for 1 h at room temperature. Immunoreactive bands were visualized by the enhanced chemiluminescence system (Clinx Science Instruments Co., Ltd., Shanghai, China) and quantitatively analyzed with Image J version l.32 J (National Institutes of Health, Bethesda, MD USA), and &#x03B2;-actin was selected as the loading control.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All statistical analyses were conducted with SPSS statistical software v.13.0 (SPSS, Inc., Chicago, IL, USA). Data are expressed as the mean &#x00B1; standard deviation standard error of the mean. The statistical significance of differences between groups was determined by one-way analysis of variance followed by Bonferroni post-hoc tests. P&#x003C;0.05 was considered to indicate a statistically significant difference. Each experiment was repeated least three times.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>NaN<sub>3</sub> inhibits the growth of PC12 cells</title>
<p>The effect of NaN<sub>3</sub> exposure on the proliferation of PC12 cells was assessed by CCK-8 assay. Cells were challenged with different concentrations (0&#x2013;80 mM) of NaN<sub>3</sub> for 12&#x2013;72 h. <xref rid="tI-mmr-19-03-2211" ref-type="table">Table I</xref> and <xref rid="f1-mmr-19-03-2211" ref-type="fig">Fig. 1A-D</xref> indicate that the cell viability was decreased by NaN<sub>3</sub> in a concentration-dependent manner. Almost 100&#x0025; of the cells died following exposure to 80 mM NaN<sub>3</sub> for 72 h, indicating that NaN<sub>3</sub> markedly induced cell death, and the cytotoxicity of NaN<sub>3</sub> was detected in a dose- and time-dependent manner. Exposure to NaN<sub>3</sub> at a concentration of 20 mM for 24 h caused marked cell death in the PC12 cells (50&#x0025;). Therefore, the cells cultured for 24 h were used for subsequent experiments.</p>
</sec>
<sec>
<title>Cell morphology</title>
<p>In DAPI staining, the morphological changes of PC12 cells were observed by fluorescence microscopy following exposure to different concentrations of NaN<sub>3</sub>. The fragmentation of cell nuclei exposed to NaN<sub>3</sub> for 24 h was observed, and cell nuclei shrinkage and chromatin condensation were increased slightly with the concentration of NaN<sub>3</sub> in PC12 cells as compared to the control. In these cells, apoptotic cells were smaller and brighter compared with normal cells. Chromatin condensation and nuclear fragmentation were also observed, whereas blue nuclei of viable cells were identified in the control group. In addition, the number of apoptotic cells and the intensity of green fluorescence were increased in cells exposed to NaN<sub>3</sub> (<xref rid="f2-mmr-19-03-2211" ref-type="fig">Fig. 2</xref>).</p>
</sec>
<sec>
<title>Apoptotic rate determination by Annexin V-FITC staining</title>
<p>Dead cells or late apoptotic cells that have lost cell membrane integrity may be stained by propidium iodide. Due to the loss of this cell membrane integrity, Annexin V-FITC may enter into the cytoplasm and combine with the phosphatidylserine inside of the cell membrane, exhibiting green fluorescence in dead cells. <xref rid="f3-mmr-19-03-2211" ref-type="fig">Fig. 3</xref> demonstrates that the numbers of apoptotic cells were 5.03, 8.02, 43.77 and 78.67&#x0025; (P&#x003C;0.05) in the PC12 cells following exposure to NaN<sub>3</sub> at different concentrations (0, 10, 20 and 40 mM) for 24 h, respectively. These results additionally confirmed that NaN<sub>3</sub> induced cell apoptosis in a dose-dependent manner.</p>
</sec>
<sec>
<title>Changes in mitochondrial membrane potential (&#x0394;&#x03A8;m)</title>
<p>Mitochondria are generally considered key regulatory organelles involved in cell viability. Therefore, &#x0394;&#x03A8;m was used as the indicator of mitochondrial function. PC12 cells were stained with JC-1, a cationic dye that exhibits potential-dependent accumulation in mitochondria. Red fluorescence (J-aggregates), representing active mitochondria with stable membrane potential, was observed in a small number of cells exposed to increasing concentrations of NaN<sub>3</sub>. By contrast, green fluorescence (J-monomer), representing apoptotic mitochondria with damaged &#x0394;&#x03A8;m, was observed in a number of cells. The ratio of red and green fluorescence gradually decreased in the control group (<xref rid="f4-mmr-19-03-2211" ref-type="fig">Fig. 4</xref>).</p>
</sec>
<sec>
<title>NaN<sub>3</sub>-induced accumulation of mitochondrial ROS</title>
<p>It is well known that mitochondria are the primary source of cellular ROS, and ROS serve an important role in activation of apoptotic signaling. Therefore, the role of ROS in NaN<sub>3</sub>-induced PC12 cell death was additionally investigated. <xref rid="f5-mmr-19-03-2211" ref-type="fig">Fig. 5</xref> indicates that the fluorescence intensities in control cells and cells exposed to NaN<sub>3</sub> at various concentrations (0, 10, 20 and 40 mM) for 24 h were 3.65, 6.99, 18.63 and 39.35, respectively, indicating that NaN<sub>3</sub> exposure significantly increased the production of mitochondrial ROS compared with the control group (P&#x003C;0.05). These results suggested that NaN<sub>3</sub>-induced apoptosis improved the production of intracellular ROS.</p>
</sec>
<sec>
<title>NaN<sub>3</sub> downregulates the mitochondrial energy production of cellular ATP</title>
<p>To evaluate the ATP content in PC12 cells exposed to NaN<sub>3</sub>, the relative luminescence unit (RLU) was quantitatively determined by a luminometer. <xref rid="f6-mmr-19-03-2211" ref-type="fig">Fig. 6</xref> indicates that NaN<sub>3</sub> inhibited mitochondrial ATP production and gradually decreased the cellular ATP level (P&#x003C;0.05).</p>
</sec>
<sec>
<title>Expression levels of Pgc-1&#x03B1; and apoptosis-associated proteins in PC12 cells</title>
<p>The Pgc-1&#x03B1; expression at the protein level was significantly decreased following NaN<sub>3</sub> exposure compared with the control (P&#x003C;0.05). In addition, Nrf-1, Tfam, p-Erk1/2, Nrf-2 and Cox IV are well-known downstream targets of Pgc-1&#x03B1; dynamics in various cell types (<xref rid="b8-mmr-19-03-2211" ref-type="bibr">8</xref>). The present study identified that NaN<sub>3</sub> exposure significantly inhibited Pgc-1&#x03B1; dynamics in a dose-dependent manner (P&#x003C;0.01; <xref rid="f7-mmr-19-03-2211" ref-type="fig">Fig. 7A</xref>).</p>
<p>In addition, NaN<sub>3</sub> exposure upregulated the expression levels of Bax and cytochrome c, while it downregulated the expression levels of Bcl-2 and procaspase-3 (P&#x003C;0.05). The ratio of Bax/Bcl-2 was also significantly increased compared with the control group (P&#x003C;0.05; <xref rid="f7-mmr-19-03-2211" ref-type="fig">Fig. 7B</xref>).</p>
<p>The protein expression levels of other important members, including CaN, CaMKII, p-CaMKII, p38 MAPK and p-p38 MAPK, were also assessed. The results indicated that NaN<sub>3</sub> increased the expression of CaN and the phosphorylation of CaMKII and p38 MAPK compared with the control group, while the expression levels of total CaMKII and p38 MAPK were not changed. In addition, the ratios of p-CaMKII/CaMKII and p-p38/p38 MAPK in the NaN<sub>3</sub> group were significantly increased compared with those in the control group (P&#x003C;0.01; <xref rid="f7-mmr-19-03-2211" ref-type="fig">Fig. 7C</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>To determine whether NaN<sub>3</sub> inhibited the proliferation of PC12 cells, the number of treated cells in the logarithmic phase was compared with the number of non-treated control cells. Cell growth was inhibited by ~75&#x0025; after 24 h of exposure to 20 mM NaN<sub>3</sub>. Therefore, this concentration was used for subsequent experiments. Apoptosis involves changes in cellular morphology, including membrane blebbing, cell shrinkage, chromatin condensation, nuclear fragmentation and DNA fragmentation (<xref rid="b9-mmr-19-03-2211" ref-type="bibr">9</xref>). To additionally analyze nuclear morphology of apoptosis and apoptotic rate, cells were challenged with 0, 10, 20 and 40 mM NaN<sub>3</sub> for 24 h. Following treatment, cells were then stained with DAPI and Annexin V-FITC/PI, and the distribution of the nuclei was analyzed. The results confirmed that NaN<sub>3</sub> exposure induced apoptosis in PC12 cells in a concentration-dependent manner.</p>
<p>Mitochondria are involved in numerous metabolic functions, including maintenance of intracellular pH and production of ROS, which promote and regulate cell apoptosis (<xref rid="b10-mmr-19-03-2211" ref-type="bibr">10</xref>). The hallmarks of cell apoptosis are preceded by mitochondrial alterations, including a loss of &#x0394;&#x03A8;m, a decrease in energy production (ATP) and an increase in permeability of the mitochondrial membrane. Previous studies have suggested that ROS trigger damage to the mitochondrial respiratory chain and induce the loss of &#x0394;&#x03A8;m, which are the factors that mediate or amplify the neuronal dysfunction during the course of the neurodegeneration, consequently leading to the development of neurodegenerative diseases (<xref rid="b11-mmr-19-03-2211" ref-type="bibr">11</xref>,<xref rid="b12-mmr-19-03-2211" ref-type="bibr">12</xref>). NaN<sub>3</sub> is known to drive degeneration and excitotoxicity by increasing the permeability potential of the mitochondrial membrane through lipid peroxidation (<xref rid="b13-mmr-19-03-2211" ref-type="bibr">13</xref>&#x2013;<xref rid="b15-mmr-19-03-2211" ref-type="bibr">15</xref>), and NaN<sub>3</sub> exerts its primary toxic action by inhibiting the function of cytochrome oxidase in the mitochondrial electron transport chain and preventing the ATP production (<xref rid="b4-mmr-19-03-2211" ref-type="bibr">4</xref>). In the present study, FCM was used to identify &#x0394;&#x03A8;m and ROS production in PC12 cells. In addition, the ATP synthesis in mitochondria was examined following exposure to various concentrations of NaN<sub>3</sub>. The disruption of the plasma membrane, the increase of mitochondrial ROS production and the decrease in cellular ATP content observed suggested that NaN<sub>3</sub> exposure induced the apoptosis in PC12 cells.</p>
<p>Mitochondrial cell death may be activated by multiple stimuli, including the developmental program, DNA damage, endoplasmic reticulum stress, growth factor and nutrient deprivation, viral infection and oxidative stress (<xref rid="b16-mmr-19-03-2211" ref-type="bibr">16</xref>). As a member of the ever-growing family of nuclear co-regulators, Pgc-1&#x03B1; may activate a large set of genes and regulate the expression levels of genes involved in energy metabolism in response to signaling pathways that mediate thermogenesis, gluconeogenesis, muscle fiber type switching and mitochondrial biogenesis (<xref rid="b17-mmr-19-03-2211" ref-type="bibr">17</xref>). These co-regulators exist and function in large multi-protein complexes, in which rather than binding to DNA, they regulate Nrf-1/2 and Tfam and modulate their transcriptional potency by promoting the subsequent biochemical interactions required for induction or repression of gene transcription (<xref rid="b8-mmr-19-03-2211" ref-type="bibr">8</xref>). In addition, Nrf-1/2 also indirectly controls the expression of mitochondrial DNA-encoded genes by potently inducing the nuclear-encoded Tfam A, B1 and B2 (Tfam, Tfb1m and Tfb2m, respectively), which are the regulators of the transcription and replication of the mitochondrial genome (<xref rid="b18-mmr-19-03-2211" ref-type="bibr">18</xref>). Previous studies have demonstrated that NaN<sub>3</sub> is an inhibitor of the mitochondrial respiratory chain complex IV, which is frequently affected in primary mitochondrial disorders (<xref rid="b19-mmr-19-03-2211" ref-type="bibr">19</xref>,<xref rid="b20-mmr-19-03-2211" ref-type="bibr">20</xref>). In the present study, the expression of Pgc-1&#x03B1; signal cascade, including Pgc-1&#x03B1; family proteins (Pgc-1&#x03B1;, Nrf-1, Nrf-2 and Tfam) and Cox IV, was first examined in PC12 cells to verify whether the signaling events were involved in NaN<sub>3</sub>-induced apoptosis. The results suggested that the NaN<sub>3</sub>-induced apoptosis was associated with the expression levels of Pgc-1&#x03B1; family proteins and Cox IV in mitochondria-mediated signaling pathway. When the concentrations of NaN<sub>3</sub> were increased, the expression levels of these proteins were significantly decreased, indicating that they may be involved in the activation and development of apoptosis.</p>
<p>Conversely, complex IV may trigger apoptosis in primary cortical neurons, which is caspase3-dependent and associated with the release of cytochrome c (<xref rid="b5-mmr-19-03-2211" ref-type="bibr">5</xref>). It is well known that mitochondria are key regulators of cell apoptosis. The Bcl-2 family proteins are the important initiators of the mitochondrial apoptotic pathway. This family includes the pro-apoptotic proteins Bax, Bcl-2 homologous antagonist/killer and Bcl-2-associated agonist of cell death and anti-apoptotic proteins Bcl-2 and Bcl-extra large (Bcl-xL). In healthy cells, Bax is an inactive cytosolic protein, but it is translocated into the mitochondria during apoptosis. It exerts its pro-apoptotic effects by forming a pore in the mitochondrial outer membrane, through which cytochrome c is released into the cytoplasm, leading to the activation of caspase 3 (<xref rid="b21-mmr-19-03-2211" ref-type="bibr">21</xref>). The anti-apoptotic proteins Bcl-2 and Bcl-xL suppress the function of Bax by maintaining integrity of mitochondrial membrane, which prevents the release of cytochrome c and the activation of caspase 3 (<xref rid="b22-mmr-19-03-2211" ref-type="bibr">22</xref>). In the present study, NaN<sub>3</sub> increased the levels of pro-apoptotic Bax and cytochrome c and decreased levels of anti-apoptotic Bcl-2 and procaspase-3, indicating that NaN<sub>3</sub> initiated mitochondrial apoptosis signaling in PC12 cells.</p>
<p>In addition, the expression levels of Pgc-1&#x03B1; co-activators are highly inducible at the transcriptional level via a variety of upstream signaling pathways. For example, the expression of Pgc-1&#x03B1; is induced by exercise and cold exposure under the control of stress signaling via cellular Ca<sup>2&#x002B;</sup> and cyclic adenosine 5&#x2032;-monophosphate (cAMP) signaling (<xref rid="b23-mmr-19-03-2211" ref-type="bibr">23</xref>). The transcription of Pgc-1&#x03B1; may be affected by CaMK, calcineurin, &#x03B2;-adrenergic receptor/cAMP and p38 MAPK (<xref rid="b24-mmr-19-03-2211" ref-type="bibr">24</xref>&#x2013;<xref rid="b26-mmr-19-03-2211" ref-type="bibr">26</xref>). In addition, p38 MAPK belonging to the MAPK family serves a pivotal function in cell proliferation, differentiation, transformation and apoptosis, since the activation of apoptosis may induce Pgc-1&#x03B1; via direct phosphorylation (<xref rid="b27-mmr-19-03-2211" ref-type="bibr">27</xref>). In the present study, the expression levels of proteins in Ca<sup>2&#x002B;</sup> signaling pathways (pan-calcineurin A and p-CaMKII/CaMKII) and p38 MAPK pathway (p-p38MAPK/p38 MAPK and p-Erk1/2) were examined to investigate the effects of NaN<sub>3</sub> on intracellular Ca<sup>2&#x002B;</sup> homeostasis and p38 MAPK. The data indicated that the protein levels of pan-calcineurin A, and the p-CaMKII/CaMKII and p-p38 MAPK/p38 MAPK ratios were increased and p-Erk1/2 level was decreased in the NaN<sub>3</sub>-treated group, suggesting that NaN<sub>3</sub> triggered the apoptosis of PC12 cells in a dose-dependent manner, and such an activation was associated with the Ca<sup>2&#x002B;</sup> and p38 MAPK pathways. Taken together, these experimental results confirmed that NaN<sub>3</sub> may induce the apoptosis of PC12 cells by activating Ca<sup>2&#x002B;</sup> and p38 MAPK pathways. To the best of our knowledge, the present study revealed for the first time that NaN<sub>3</sub> induced mitochondria-mediated apoptosis in PC12 cells through Pgc-1&#x03B1;-associated signaling pathways, including Ca<sup>2&#x002B;</sup>/p-CaMKII and p38 MAPK.</p>
<p>In summary, the present study demonstrated that NaN<sub>3</sub> may induce the apoptosis of PC12 cells. In order to elucidate the underlying toxic mechanism of NaN<sub>3</sub> exposure, the expression levels of a series of pro-apoptotic proteins (Bax and cytochrome c) and anti-apoptotic proteins (Bcl-2, procaspase-3, p-p38 MAPK, p-CaMKII and Pgc-1&#x03B1;) were examined. The results confirmed that pro-apoptotic proteins exerted pro-apoptotic effects on PC12 cells via activation and phosphorylation of CaMKII and p38 MAPK, which stimulated the activation of Pgc-1&#x03B1; and procaspase-3 in PC12 cells. The data provide a basis for subsequent studies investigating NaN<sub>3</sub> mechanisms of action at the molecular level. Future studies may include the addition of protective agents, for example mitochondrial division inhibitor 1, a derivative of quinazolinone that is a newly-identified mitochondrial division inhibitor, prior to NaN<sub>3</sub> treatment, in order to investigate the neuroprotective effects of the protective agent in attenuating NaN<sub>3</sub>-induced apoptosis in PC12 cells, and to additionally elucidate the underlying mechanism.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec>
<title>Funding</title>
<p>The present study was financially supported by the grants from the National Natural Science Foundation of China (grant no. 81571848) and the Priority Academic Program Development of Jiangsu Higher Education Institutions.</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>The datasets used or analyzed during the present study are available from the corresponding author on reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>YZ and SZ conceived and designed the study. YZ, JH, HX, TG and YW acquired the data. YZ, JH and HX analyzed and interpreted the data, and drafted the manuscript. All authors critically revised the manuscript, and read and approved the final version of the manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>NaN<sub>3</sub></term><def><p>sodium azide</p></def></def-item>
<def-item><term>Cox IV</term><def><p>complex IV</p></def></def-item>
<def-item><term>Tfam</term><def><p>mitochondrial transcription factor A</p></def></def-item>
<def-item><term>Nrf-1/2</term><def><p>nuclear respiratory factor-1/2</p></def></def-item>
<def-item><term>CaN</term><def><p>pan-calcineurin A</p></def></def-item>
<def-item><term>Pgc-1&#x03B1;</term><def><p>peroxisome proliferator-activated receptor &#x03B3; co-activator 1-&#x03B1;</p></def></def-item>
<def-item><term>PC12</term><def><p>rat pheochromocytoma</p></def></def-item>
<def-item><term>&#x0394;&#x03A8;m</term><def><p>mitochondrial membrane potential</p></def></def-item>
<def-item><term>CCCP</term><def><p>carbonyl cyanide 3-chlorophenylhydrazone</p></def></def-item>
<def-item><term>ROS</term><def><p>reactive oxygen species</p></def></def-item>
<def-item><term>FCM</term><def><p>flow cytometry</p></def></def-item>
<def-item><term>MAPK</term><def><p>mitogen-activated protein kinase</p></def></def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="b1-mmr-19-03-2211"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbold</surname><given-names>M</given-names></name><name><surname>Schmitt</surname><given-names>G</given-names></name><name><surname>Aderjan</surname><given-names>R</given-names></name><name><surname>Pedal</surname><given-names>I</given-names></name></person-group><article-title>Fatal sodium azide poisoning in a hospital: A preventable accident</article-title><source>Arch Kriminol</source><volume>196</volume><fpage>143</fpage><lpage>148</lpage><year>1995</year><comment>(In German)</comment><pub-id pub-id-type="pmid">8585783</pub-id></element-citation></ref>
<ref id="b2-mmr-19-03-2211"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquet</surname><given-names>P</given-names></name><name><surname>Cl&#x00E9;ment</surname><given-names>S</given-names></name><name><surname>Lotfi</surname><given-names>H</given-names></name><name><surname>Dreyfuss</surname><given-names>MF</given-names></name><name><surname>Debord</surname><given-names>J</given-names></name><name><surname>Dumont</surname><given-names>D</given-names></name><name><surname>Lach&#x00E2;tre</surname><given-names>G</given-names></name></person-group><article-title>Analytical findings in a suicide involving sodium azide</article-title><source>J Anal Toxicol</source><volume>20</volume><fpage>134</fpage><lpage>138</lpage><year>1996</year><pub-id pub-id-type="doi">10.1093/jat/20.2.134</pub-id><pub-id pub-id-type="pmid">8868407</pub-id></element-citation></ref>
<ref id="b3-mmr-19-03-2211"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Lamm</surname><given-names>SH</given-names></name></person-group><article-title>Human health effects of sodium azide exposure: A literature review and analysis</article-title><source>Int J Toxicol</source><volume>22</volume><fpage>175</fpage><lpage>186</lpage><year>2003</year><pub-id pub-id-type="doi">10.1080/10915810305109</pub-id><pub-id pub-id-type="pmid">12851150</pub-id></element-citation></ref>
<ref id="b4-mmr-19-03-2211"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leary</surname><given-names>SC</given-names></name><name><surname>Hills</surname><given-names>BC</given-names></name><name><surname>Lyons</surname><given-names>CN</given-names></name><name><surname>Carison</surname><given-names>CG</given-names></name><name><surname>Michaud</surname><given-names>D</given-names></name><name><surname>Kraft</surname><given-names>CS</given-names></name><name><surname>Ko</surname><given-names>K</given-names></name><name><surname>Glerum</surname><given-names>DM</given-names></name><name><surname>Moyes</surname><given-names>CD</given-names></name></person-group><article-title>Chronic treatment with azide in situ leads to an irreversible loss of cytochrome c oxidase activity via holoenzyme dissociation</article-title><source>J Biol Chem</source><volume>277</volume><fpage>11321</fpage><lpage>11328</lpage><year>2002</year><pub-id pub-id-type="doi">10.1074/jbc.M112303200</pub-id><pub-id pub-id-type="pmid">11796734</pub-id></element-citation></ref>
<ref id="b5-mmr-19-03-2211"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grammatopoulos</surname><given-names>TN</given-names></name><name><surname>Morris</surname><given-names>K</given-names></name><name><surname>Bachar</surname><given-names>C</given-names></name><name><surname>Moore</surname><given-names>S</given-names></name><name><surname>Andres</surname><given-names>R</given-names></name><name><surname>Weyhenmeyer</surname><given-names>JA</given-names></name></person-group><article-title>AngiotensinII attenuates chemical hypoxia-induced caspase-3 activation in primary cortical neuronal cultures</article-title><source>Brain Res Bull</source><volume>62</volume><fpage>297</fpage><lpage>303</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.brainresbull.2003.09.018</pub-id><pub-id pub-id-type="pmid">14709344</pub-id></element-citation></ref>
<ref id="b6-mmr-19-03-2211"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scarpulla</surname><given-names>RC</given-names></name></person-group><article-title>Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network</article-title><source>Biochim Biophys Acta 1813</source><fpage>1269</fpage><lpage>1278</lpage><year>2011</year></element-citation></ref>
<ref id="b7-mmr-19-03-2211"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>JB</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group><article-title>The role of Pgc-1&#x03B1; and mitochondrial regulation in cardiovascular disease</article-title><source>Chinese Pharmacol Bull</source><volume>29</volume><fpage>1</fpage><lpage>5</lpage><year>2013</year></element-citation></ref>
<ref id="b8-mmr-19-03-2211"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>AW</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Vicencio</surname><given-names>JM</given-names></name><name><surname>Karkucinska-Wieckowska</surname><given-names>A</given-names></name><name><surname>Szabadkai</surname><given-names>G</given-names></name></person-group><article-title>PGC-1 family coactivators and cell fate: Roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signaling</article-title><source>Mitochondrion</source><volume>12</volume><fpage>86</fpage><lpage>99</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.mito.2011.09.009</pub-id><pub-id pub-id-type="pmid">21983689</pub-id></element-citation></ref>
<ref id="b9-mmr-19-03-2211"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>JFR</given-names></name><name><surname>Winterford</surname><given-names>CM</given-names></name><name><surname>Harmon</surname><given-names>BV</given-names></name></person-group><article-title>Apoptosis: Its significance in cancer and cancer therapy</article-title><source>Cancer</source><volume>73</volume><fpage>2013</fpage><lpage>2026</lpage><year>1994</year><pub-id pub-id-type="doi">10.1002/1097-0142(19940415)73:8&#x003C;2013::AID-CNCR2820730802&#x003E;3.0.CO;2-J</pub-id><pub-id pub-id-type="pmid">8156506</pub-id></element-citation></ref>
<ref id="b10-mmr-19-03-2211"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>DC</given-names></name></person-group><article-title>Mitochondria: Dynamic organelles in disease, ageing and development</article-title><source>Cell</source><volume>125</volume><fpage>1241</fpage><lpage>1252</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.cell.2006.06.010</pub-id><pub-id pub-id-type="pmid">16814712</pub-id></element-citation></ref>
<ref id="b11-mmr-19-03-2211"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>MT</given-names></name></person-group><article-title>Oxidative stress and mitochondrial dysfunctionlinked neurodegenerative disorders</article-title><source>Neurol Res</source><volume>39</volume><fpage>73</fpage><lpage>82</lpage><year>2017</year><pub-id pub-id-type="doi">10.1080/01616412.2016.1251711</pub-id><pub-id pub-id-type="pmid">27809706</pub-id></element-citation></ref>
<ref id="b12-mmr-19-03-2211"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>RK</given-names></name><name><surname>Flint</surname><given-names>BM</given-names></name></person-group><article-title>Mitochondrial diseases of the brain</article-title><source>Free Radic Biol Med</source><volume>63</volume><fpage>1</fpage><lpage>29</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.03.018</pub-id><pub-id pub-id-type="pmid">23567191</pub-id></element-citation></ref>
<ref id="b13-mmr-19-03-2211"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Laar</surname><given-names>VS</given-names></name><name><surname>Roy</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Raiprohat</surname><given-names>S</given-names></name><name><surname>Arnold</surname><given-names>B</given-names></name><name><surname>Dukes</surname><given-names>AA</given-names></name><name><surname>Holbein</surname><given-names>CD</given-names></name><name><surname>Berman</surname><given-names>SB</given-names></name></person-group><article-title>Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin and in the presence of N-acetyl cysteine, mitophagy</article-title><source>Neurobiol Dis</source><volume>74</volume><fpage>180</fpage><lpage>193</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.nbd.2014.11.015</pub-id><pub-id pub-id-type="pmid">25478815</pub-id></element-citation></ref>
<ref id="b14-mmr-19-03-2211"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Peritore</surname><given-names>C</given-names></name><name><surname>Ginsberg</surname><given-names>J</given-names></name><name><surname>Shinh</surname><given-names>J</given-names></name><name><surname>Arun</surname><given-names>S</given-names></name><name><surname>Donmez</surname><given-names>G</given-names></name></person-group><article-title>Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson&#x0027;s disease</article-title><source>Behav Brain Res</source><volume>281</volume><fpage>215</fpage><lpage>221</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.bbr.2014.12.035</pub-id><pub-id pub-id-type="pmid">25541039</pub-id></element-citation></ref>
<ref id="b15-mmr-19-03-2211"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palomo</surname><given-names>GM</given-names></name><name><surname>Manfredi</surname><given-names>G</given-names></name></person-group><article-title>Exploring new pathways of neurodegeneration in ALS: The role of mitochondria quality control</article-title><source>Brain Res 1607</source><fpage>36</fpage><lpage>46</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.brainres.2014.09.065</pub-id></element-citation></ref>
<ref id="b16-mmr-19-03-2211"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youle</surname><given-names>RJ</given-names></name><name><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>The BCL-2 protein family: Opposing activities that mediate cell death</article-title><source>Nat Rev Mol Cell Biol</source><volume>9</volume><fpage>47</fpage><lpage>59</lpage><year>2008</year><pub-id pub-id-type="doi">10.1038/nrm2308</pub-id><pub-id pub-id-type="pmid">18097445</pub-id></element-citation></ref>
<ref id="b17-mmr-19-03-2211"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vercauteren</surname><given-names>K</given-names></name><name><surname>Pasko</surname><given-names>RA</given-names></name><name><surname>Gleyzer</surname><given-names>N</given-names></name><name><surname>Marino</surname><given-names>VM</given-names></name><name><surname>Scarpulla</surname><given-names>RC</given-names></name></person-group><article-title>PGC-1-related coactivator: Immediate early expression and characterization of a CREB/NRF-1 binding domain associated with cytochrome c promoter occupancy and respiratory growth</article-title><source>Mol Cell Biol</source><volume>26</volume><fpage>7409</fpage><lpage>7419</lpage><year>2006</year><pub-id pub-id-type="doi">10.1128/MCB.00585-06</pub-id><pub-id pub-id-type="pmid">16908542</pub-id><pub-id pub-id-type="pmcid">1636882</pub-id></element-citation></ref>
<ref id="b18-mmr-19-03-2211"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scarpulla</surname><given-names>RC</given-names></name></person-group><article-title>Transcriptional paradigms in mammalian mitochondrial biogenesis and function</article-title><source>Physiol Rev</source><volume>88</volume><fpage>611</fpage><lpage>638</lpage><year>2008</year><pub-id pub-id-type="doi">10.1152/physrev.00025.2007</pub-id><pub-id pub-id-type="pmid">18391175</pub-id></element-citation></ref>
<ref id="b19-mmr-19-03-2211"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betts</surname><given-names>J</given-names></name><name><surname>Lightowlers</surname><given-names>RN</given-names></name><name><surname>Turnbull</surname><given-names>DM</given-names></name></person-group><article-title>Neuropathological aspects of mitochondrial DNA disease</article-title><source>Neurochem Res</source><volume>29</volume><fpage>505</fpage><lpage>511</lpage><year>2004</year><pub-id pub-id-type="doi">10.1023/B:NERE.0000014821.07269.8d</pub-id><pub-id pub-id-type="pmid">15038598</pub-id></element-citation></ref>
<ref id="b20-mmr-19-03-2211"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanji</surname><given-names>K</given-names></name><name><surname>Kunimatsu</surname><given-names>T</given-names></name><name><surname>Vu</surname><given-names>TH</given-names></name><name><surname>Bonilla</surname><given-names>E</given-names></name></person-group><article-title>Neuropathological features of mitochondrial disorders</article-title><source>Semin Cell Dev Biol</source><volume>12</volume><fpage>429</fpage><lpage>439</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/scdb.2001.0280</pub-id><pub-id pub-id-type="pmid">11735377</pub-id></element-citation></ref>
<ref id="b21-mmr-19-03-2211"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aluvila</surname><given-names>S</given-names></name><name><surname>Mandal</surname><given-names>T</given-names></name><name><surname>Hustedt</surname><given-names>E</given-names></name><name><surname>Fajer</surname><given-names>P</given-names></name><name><surname>Choe</surname><given-names>JY</given-names></name><name><surname>Oh</surname><given-names>KJ</given-names></name></person-group><article-title>Organization of the mitochondrial apoptotic BAK pore: Oligomerization of the BAK homodimers</article-title><source>J Biol Chem</source><volume>289</volume><fpage>2537</fpage><lpage>2551</lpage><year>2014</year><pub-id pub-id-type="doi">10.1074/jbc.M113.526806</pub-id><pub-id pub-id-type="pmid">24337568</pub-id></element-citation></ref>
<ref id="b22-mmr-19-03-2211"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>E</given-names></name><name><surname>Zha</surname><given-names>J</given-names></name><name><surname>Jockel</surname><given-names>J</given-names></name><name><surname>Boise</surname><given-names>LH</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name><name><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death</article-title><source>Cell</source><volume>80</volume><fpage>285</fpage><lpage>291</lpage><year>1995</year><pub-id pub-id-type="doi">10.1016/0092-8674(95)90411-5</pub-id><pub-id pub-id-type="pmid">7834748</pub-id></element-citation></ref>
<ref id="b23-mmr-19-03-2211"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hock</surname><given-names>MB</given-names></name><name><surname>Kralli</surname><given-names>A</given-names></name></person-group><article-title>Transcriptional control of mitochondrial biogenesis and function</article-title><source>Annu Rev Physiol</source><volume>71</volume><fpage>177</fpage><lpage>203</lpage><year>2009</year><pub-id pub-id-type="doi">10.1146/annurev.physiol.010908.163119</pub-id><pub-id pub-id-type="pmid">19575678</pub-id></element-citation></ref>
<ref id="b24-mmr-19-03-2211"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handschin</surname><given-names>C</given-names></name><name><surname>Rhee</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Tarr</surname><given-names>PT</given-names></name><name><surname>Spieglman</surname><given-names>BM</given-names></name></person-group><article-title>An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle</article-title><source>Proc Natl Acad Sci USA</source><volume>100</volume><fpage>7111</fpage><lpage>7116</lpage><year>2003</year><pub-id pub-id-type="doi">10.1073/pnas.1232352100</pub-id><pub-id pub-id-type="pmid">12764228</pub-id></element-citation></ref>
<ref id="b25-mmr-19-03-2211"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaeffer</surname><given-names>PJ</given-names></name><name><surname>Wende</surname><given-names>AR</given-names></name><name><surname>Magee</surname><given-names>CJ</given-names></name><name><surname>Neilson</surname><given-names>JR</given-names></name><name><surname>Leone</surname><given-names>TC</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Kelly</surname><given-names>DP</given-names></name></person-group><article-title>Calcineurin and calcium/calmodulin-dependent protein kinase activate distinct metabolic gene regulatory programs in cardiac muscle</article-title><source>J Biol Chem</source><volume>279</volume><fpage>593</fpage><lpage>603</lpage><year>2004</year><pub-id pub-id-type="doi">10.1074/jbc.M403649200</pub-id></element-citation></ref>
<ref id="b26-mmr-19-03-2211"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohas</surname><given-names>LM</given-names></name><name><surname>St-Pierre</surname><given-names>J</given-names></name><name><surname>Uldry</surname><given-names>M</given-names></name><name><surname>J&#x00E4;ger</surname><given-names>S</given-names></name><name><surname>Handschin</surname><given-names>S</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><article-title>A fundamental system of cellular energy homeostasis regulated by PGC-1 alpha</article-title><source>Proc Natl Acad Sci USA</source><volume>104</volume><fpage>7933</fpage><lpage>7938</lpage><year>2007</year><pub-id pub-id-type="doi">10.1073/pnas.0702683104</pub-id><pub-id pub-id-type="pmid">17470778</pub-id></element-citation></ref>
<ref id="b27-mmr-19-03-2211"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puigserver</surname><given-names>P</given-names></name><name><surname>Rhee</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Yoon</surname><given-names>JC</given-names></name><name><surname>Zhang</surname><given-names>CY</given-names></name><name><surname>Krauss</surname><given-names>S</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><article-title>Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1</article-title><source>Mol Cell</source><volume>8</volume><fpage>971</fpage><lpage>982</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S1097-2765(01)00390-2</pub-id><pub-id pub-id-type="pmid">11741533</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-19-03-2211" position="float">
<label>Figure 1.</label>
<caption><p>NaN<sub>3</sub> suppresses cell viability in cultured PC12 cells. Following exposure to 0, 5, 10, 20, 40 and 80 mM NaN<sub>3</sub> for 24 h, the survival rate was decreased to 100, 39.33&#x00B1;3.99, 34.86&#x00B1;7.98, 24.89&#x00B1;3.33, 16.89&#x00B1;0.73 and 7.35&#x00B1;2.55&#x0025;, respectively. The cytotoxicity in PC12 cells was detected at (A) 12, (B) 24, (C) 48 and (D) 72 h by CCK-8 assay. &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. the control group. NaN<sub>3,</sub> sodium azide.</p></caption>
<graphic xlink:href="MMR-19-03-2211-g00.tif"/>
</fig>
<fig id="f2-mmr-19-03-2211" position="float">
<label>Figure 2.</label>
<caption><p>Effects of NaN<sub>3</sub> on nuclear morphology in PC12 cells. Morphological changes of PC12 cells were revealed by DAPI staining and visualized under fluorescence microscopy upon exposure to different concentrations of NaN<sub>3</sub> (0, 10, 20 and 40 mM). Arrows indicates NaN<sub>3</sub>-induced nuclear shrinkage and chromatin condensation. Magnification, &#x00D7;200. NaN<sub>3,</sub> sodium azide.</p></caption>
<graphic xlink:href="MMR-19-03-2211-g01.tif"/>
</fig>
<fig id="f3-mmr-19-03-2211" position="float">
<label>Figure 3.</label>
<caption><p>Detection of cell apoptosis in PC12 cells by Annexin V-FITC/PI staining. Cells were exposed to different concentrations of NaN<sub>3</sub> (0, 10, 20 and 40 mM) for 24 h. (A) PC12 cells were stained with Annexin V-FITC/PI and analyzed by flow cytometry. (B) Quantitative analysis of NaN<sub>3</sub>-induced apoptosis. Proportions of apoptotic cells are presented as mean &#x00B1; standard deviation (n=3). &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. the control group. FITC, fluorescein isothiocyanate; PI, propidium iodide; NaN<sub>3,</sub> sodium azide.</p></caption>
<graphic xlink:href="MMR-19-03-2211-g02.tif"/>
</fig>
<fig id="f4-mmr-19-03-2211" position="float">
<label>Figure 4.</label>
<caption><p>NaN<sub>3</sub> exposure decreases the &#x0394;&#x03A8;m. Cells were exposed to different concentrations of NaN<sub>3</sub> (0, 10, 20 and 40 mM) for 24 h. &#x0394;&#x03A8;m was detected by flow cytometry. The ratio of red/green fluorescence was calculated to assess the relative &#x0394;&#x03A8;m. Data were expressed as mean &#x00B1; standard deviation (n=3). &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. the control group. NaN<sub>3,</sub> sodium azide; &#x0394;&#x03A8;m, mitochondrial membrane potential.</p></caption>
<graphic xlink:href="MMR-19-03-2211-g03.tif"/>
</fig>
<fig id="f5-mmr-19-03-2211" position="float">
<label>Figure 5.</label>
<caption><p>Effects of NaN<sub>3</sub> on ROS level in PC12 cells. Cells were exposed to different concentrations of NaN<sub>3</sub> (0, 10, 20 and 40 mM) for 24 h. (A) The fluorescence intensity was measured by flow cytometry. (B) Quantitative analysis of the ROS level. NaN<sub>3</sub> exposure significantly increased the production of mitochondrial ROS compared with the control group. Data were expressed as the means &#x00B1; standard deviation (n=3). &#x002A;&#x002A;P&#x003C;0.01 vs. the control group. NaN<sub>3,</sub> sodium azide; ROS, reactive oxygen species; MFI, mean fluorescence intensity.</p></caption>
<graphic xlink:href="MMR-19-03-2211-g04.tif"/>
</fig>
<fig id="f6-mmr-19-03-2211" position="float">
<label>Figure 6.</label>
<caption><p>NaN<sub>3</sub> inhibits the production of intracellular ATP. Cells were exposed to NaN<sub>3</sub> for 24 h, and the ATP level in PC12 cells was measured with an enhanced ATP assay kit. Data were expressed as mean &#x00B1; standard deviation (n=3). &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. the control group. NaN<sub>3,</sub> sodium azide; ATP, adenosine 5&#x2032;-triphosphate.</p></caption>
<graphic xlink:href="MMR-19-03-2211-g05.tif"/>
</fig>
<fig id="f7-mmr-19-03-2211" position="float">
<label>Figure 7.</label>
<caption><p>NaN<sub>3</sub> induces mitochondria-mediated apoptosis through the expression of Pgc-1&#x03B1;-associated proteins in PC12 cells. (A) Expression levels of Pgc-1&#x03B1;, Nrf-1, Nrf-2, Tfam and Cox IV detected by western blot analysis. (B) Expression levels of procaspase-3, Bax, Bcl-2 and cyt-c detected by western blot analysis. (C) Expression levels of pan-calcineurin A, CaMKII, p-CaMKII, p38 MAPK, p-p38 MAPK, Erk1/2 and p-Erk1/2 detected by western blot analysis. &#x03B2;-actin and GAPDH were used as the internal control. Band intensity ratios for each group are presented as mean &#x00B1; standard deviation (n=3). &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. the control group. Pgc-1&#x03B1;, peroxisome proliferator-activated receptor &#x03B3; co-activator 1-&#x03B1;; Nrf-1/2, nuclear respiratory factor-1/2; Tfam. Mitochondrial transcription factor A; Cox IV, complex IV; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein; cyt-c, cytochrome c; CaMKII, Ca<sup>2&#x002B;</sup>/calmodulin-dependent protein kinase II; p, phosphorylated; p38 MAPK, p38 mitogen-activated protein kinase; Erk1/2, extracellular signal-regulated kinase 1/2.</p></caption>
<graphic xlink:href="MMR-19-03-2211-g06.tif"/>
</fig>
<table-wrap id="tI-mmr-19-03-2211" position="float">
<label>Table I.</label>
<caption><p>NaN<sub>3</sub> suppresses the growth of PC12 cells (n=6).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="4">Time interval, h (&#x0025; viability)</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="4"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">NaN<sub>3</sub> concentration (mmol/l)</th>
<th align="center" valign="bottom">12</th>
<th align="center" valign="bottom">24</th>
<th align="center" valign="bottom">48</th>
<th align="center" valign="bottom">72</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;0</td>
<td align="center" valign="top">100</td>
<td align="center" valign="top">100</td>
<td align="center" valign="top">100</td>
<td align="center" valign="top">100</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;5</td>
<td align="center" valign="top">98.21&#x00B1;7.84</td>
<td align="center" valign="top">39.33&#x00B1;3.99</td>
<td align="center" valign="top">33.69&#x00B1;3.34</td>
<td align="center" valign="top">27.29&#x00B1;12.99</td>
</tr>
<tr>
<td align="left" valign="top">10</td>
<td align="center" valign="top">95.94&#x00B1;1.47</td>
<td align="center" valign="top">34.86&#x00B1;7.98</td>
<td align="center" valign="top">26.06&#x00B1;3.22</td>
<td align="center" valign="top">19.7&#x00B1;9.91</td>
</tr>
<tr>
<td align="left" valign="top">20</td>
<td align="center" valign="top">90.57&#x00B1;2.87</td>
<td align="center" valign="top">24.89&#x00B1;3.33</td>
<td align="center" valign="top">12.99&#x00B1;2.83</td>
<td align="center" valign="top">7.52&#x00B1;4.65</td>
</tr>
<tr>
<td align="left" valign="top">40</td>
<td align="center" valign="top">87.21&#x00B1;0.46</td>
<td align="center" valign="top">16.89&#x00B1;0.73</td>
<td align="center" valign="top">4.40&#x00B1;1.36</td>
<td align="center" valign="top">2.19&#x00B1;1.49</td>
</tr>
<tr>
<td align="left" valign="top">80</td>
<td align="center" valign="top">74.78&#x00B1;2.97</td>
<td align="center" valign="top">7.35&#x00B1;2.55</td>
<td align="center" valign="top">1.37&#x00B1;0.73</td>
<td align="center" valign="top">0.65&#x00B1;1.44</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-mmr-19-03-2211"><p>Data are presented as the mean &#x00B1; standard deviation. NaN<sub>3,</sub> sodium azide.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>